Congruence Therapeutics logo

Congruence Therapeutics

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
13
Total Funding
$97M
Investors
13 investors across all rounds
AR
Alexandria Real Estate Equities
AV
Amplitude Ventures
AV
Angelini Ventures
VENTURE_CAPITAL
BC
BDC Capital
ASSET_MANAGER
CD
Clarissa Desjardins

+8 more investors

Sign in to view all

Explore More Data
Detailed analysis for Congruence Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Congruence Therapeutics Leadership & Investors

Congruence Therapeutics is led by a team of experienced leaders. The company has attracted investment from 13 institutional and strategic investors.

Who Has Invested in Congruence Therapeutics?

Congruence Therapeutics has raised $97M from 13 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access Congruence Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.